drugset / Trial / NCT02305316
Single-dose Pharmacokinetics and Relative Bioavailability of Two Different Formulations of Opicapone
RandomizedCrossoverOpen-labelTreatment
Summary
Single-centre, open-label, randomised, two-way crossover study in 28 healthy volunteers. The study consisted of two consecutive single-dose treatment periods separated by a washout period of 14 days or more.
Timeline
- Start
- 2014-02
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Opicapone | Small molecule | 50 mg | Oral |